REGN vs AMGN
REGN 与 AMGN 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | REGNREGENERON PHARMACEUTICALS, INC. | AMGNAmgen Inc. |
|---|---|---|
| 市值 | — | $251.99B |
| 市盈率(TTM) | 20.5 | 29.0 |
| 市净率 | — | 21.56 |
| 市销率 | — | 6.9x |
| 股息率 | — | 2.03% |
| 营收 | $16.90B(TTM) | $38.09B(TTM) |
| 营收同比增长 | 1.0% | 10.0% |
| 净利润 | $4.82B(TTM) | $8.74B(TTM) |
| 净利同比增长 | 2.1% | 88.5% |
| 每股收益(稀释) | $45.24(TTM) | $16.10(TTM) |
| 息税前利润率 | 24.9% | 24.7% |
| 净资产收益率 | 13.4% | 66.0% |
| 投入资本回报率 | 9.2% | 15.1% |
| 一年总回报 | +41.7% | +62.9% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:REGN vs AMGN
| 指标 | REGN | AMGN |
|---|---|---|
| 期末价值 | $26.9K | $42.1K |
| 总回报 | +169.3% | +320.8% |
| 年化收益 (CAGR) | +10.1% | +14.9% |
| 波动率 | 32.3% | 25.1% |
| 夏普比率 | 0.33 | 0.51 |
| 索提诺比率 | 0.49 | 0.76 |
| 最大回撤 | -59.7% | -24.9% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)